S&P 500

5.222,68

0,16%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Portage Biotech Inc (PRTG)
Portage Biotech Inc (PRTG) Notícias

PRTG

Portage Biotech (PRTG)

Portage Biotech Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:PRTG

1

Data	Hora	Fonte	Título	Código	Companhia
12/04/2024	09:01	GlobeNewswire Inc.	Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives	NASDAQ:PRTG	Portage Biotech Inc
26/03/2024	09:01	GlobeNewswire Inc.	Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares	NASDAQ:PRTG	Portage Biotech Inc
08/03/2024	19:30	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PRTG	Portage Biotech Inc
08/03/2024	19:04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRTG	Portage Biotech Inc
28/02/2024	19:10	GlobeNewswire Inc.	Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update	NASDAQ:PRTG	Portage Biotech Inc
14/02/2024	17:50	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PRTG	Portage Biotech Inc
04/01/2024	10:00	GlobeNewswire Inc.	Portage Biotech Reports Business and Strategic Update	NASDAQ:PRTG	Portage Biotech Inc
01/12/2023	18:05	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PRTG	Portage Biotech Inc
08/11/2023	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PRTG	Portage Biotech Inc
06/11/2023	10:01	GlobeNewswire Inc.	Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	NASDAQ:PRTG	Portage Biotech Inc
31/10/2023	17:05	Edgar (US Regulatory)	Form F-1 - Registration statement for certain foreign private issuers	NASDAQ:PRTG	Portage Biotech Inc
31/07/2023	18:12	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:PRTG	Portage Biotech Inc
21/06/2023	07:04	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:PRTG	Portage Biotech Inc
13/10/2022	07:01	Edgar (US Regulatory)	Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)	NASDAQ:PRTG	Portage Biotech Inc
08/08/2022	07:26	TipRanks	Portage Biotech Inc (PRTG) Receives a Buy from H.C. Wainwright	NASDAQ:PRTG	Portage Biotech Inc
01/08/2022	18:14	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:PRTG	Portage Biotech Inc
08/07/2022	07:25	TipRanks	Analysts Are Bullish on Top Healthcare Stocks: Aeterna Zentaris (AEZS), Portage Biotech Inc (PRTG)	NASDAQ:PRTG	Portage Biotech Inc
04/04/2022	07:15	TipRanks	Wall Street Analysts Are Bullish on Top Healthcare Picks	NASDAQ:PRTG	Portage Biotech Inc
04/03/2022	08:05	Edgar (US Regulatory)	Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)	NASDAQ:PRTG	Portage Biotech Inc
26/10/2021	11:13	TipRanks	2 ‘Strong Buy’ Stocks Oppenheimer Predicts Will Surge at Least 50%	NASDAQ:PRTG	Portage Biotech Inc
24/06/2021	18:28	Edgar (US Regulatory)	Voluntary Supplemental Material Filed Pursuant to Section 11(a) of the Securities Act of 1933 by Foreign Issuers (suppl)	NASDAQ:PRTG	Portage Biotech Inc
09/03/2021	08:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PRTG	Portage Biotech Inc
08/03/2021	19:01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NASDAQ:PRTG	Portage Biotech Inc